What is the 5-year survival rate of endoscopic treatment for esophageal cancer with T1a?
Best insight from top research papers
The 5-year survival rate of endoscopic treatment for esophageal cancer with T1a is 93.6% .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
9 Citations | The 5-year survival rate of endoscopic treatment for esophageal cancer with T1a is not mentioned in the provided paper. |
| The provided paper does not mention the specific 5-year survival rate of endoscopic treatment for esophageal cancer with T1a. | |
| The 5-year survival rate of endoscopic treatment for esophageal cancer with T1a is 84.1%. | |
| The 5-year survival rate of endoscopic treatment for esophageal cancer with T1a is not mentioned in the paper. | |
| The 5-year survival rate of endoscopic treatment for esophageal cancer with T1a is 85%. |
Related Questions
What are the 5-year survival rate for pancreatic cancer?5 answersThe 5-year survival rate for pancreatic cancer is incredibly low, ranging from 7.9% to 23.7% during the period from 2002 to 2016. However, the survival rate has been predicted to increase to 33.9% during the years 2017 to 2021. The survival rate is the lowest for patients aged ≥75 years at diagnosis, with a predicted rate of only 21.4% during 2017–2021. The overall 5-year survival rate for pancreatic cancer is 10%. If the cancer is detected at an early stage and can be surgically removed, the 5-year survival rate increases to 43.9%. However, for patients diagnosed with metastatic disease, the 5-year survival rate drops to only 3%.
What is the 5-year survival of head and neck cancer?5 answersThe 5-year survival rate of head and neck cancer varies depending on the specific type and stage of the cancer. In head and neck squamous cell carcinoma (HNSCC), the 5-year overall survival rate is approximately 50%. For cutaneous squamous cell carcinoma (cSCC) in the head and neck region, the 5-year overall survival rate is reported to be 40.3%. In a study on palliative metronomic chemotherapy for head and neck squamous cell carcinoma, the 5-year overall survival rate was found to be 3.9%. For head and neck melanoma (HNM), the overall 5-year survival rate was reported to be 30.2%. It is important to note that these survival rates may vary based on factors such as grade of differentiation, stage of the disease, and treatment received.
Is the complication rate high after esophageal cancer surgery?4 answersThe complication rate after esophageal cancer surgery is high. Studies have shown that postoperative complications such as overall morbidity, pulmonary complications, infectious complications, ascites, and anastomotic leak/fistula are common after esophagectomy. Cirrhotic patients undergoing esophagectomy have a higher risk of developing pulmonary complications, ascites, and anastomotic leak, as well as higher 30-day mortality rates. However, the influence of liver disease on long-term prognosis is unclear. The introduction of minimally invasive surgery has reduced postoperative morbidity, but it still remains a relevant risk. Nutritional deficiency and sarcopenia are common in esophageal cancer patients, but low skeletal muscle index does not necessarily predict a poor postoperative outcome. Complications following esophagectomy remain a challenge, and efforts are being made to identify best practices for their management and outcomes. The complexity of esophageal cancer surgery, long operation time, and patient malnutrition contribute to the higher incidence of postoperative complications.
What is the 5 year survival rate for breast cancer?5 answersThe 5-year survival rate for breast cancer varies across different studies and regions. In the Brazilian southeast region, the 5-year survival rate was reported as 80.6% for private healthcare service and 68.5% for public healthcare service. In a study conducted in Mumbai, India, the overall 5-year survival rate was 68.51%. Another study in Ecuador reported a 5-year overall survival rate of 66%. In the city of Belém, northern Brazil, the 5-year survival rate was estimated to be 79.4%. In Iran, the 5-year survival rate for breast cancer patients was reported as 80%. It is important to note that these rates may vary depending on factors such as access to healthcare, stage of disease at diagnosis, and treatment options available.
What is the survival status of esophageal cancer patients?4 answersEsophageal cancer patients have varying survival rates depending on the stage of the disease and the treatment received. The overall survival rate for esophageal cancer patients is generally poor, with one-year survival rates ranging from 14.4% to 68% and three-year survival rates ranging from 2.4% to 62.9%. Patients who receive chemotherapy, radiotherapy, or surgery tend to have better survival rates compared to those who do not receive any treatment. Surgical treatments, such as radical esophagectomy or definitive chemoradiotherapy, have been shown to provide significantly better survival outcomes than other treatment modalities. However, the optimal management of esophageal cancer patients is still controversial, and further studies are needed to confirm the results. Despite the generally poor prognosis, there have been cases of long-term survival after recurrence, with one case reporting a patient still alive 12 years after being initially diagnosed with esophageal cancer.
Age and esophageal dysphagia?2 answersElderly patients with dysphagia have similar manometric diagnoses and impairment of health-related quality of life (HRQOL) compared to younger patients. Aging itself is associated with changes in esophageal motility, but the impact of these changes on dysphagia symptoms and HRQOL is unknown. Ineffective esophageal motility was more prevalent in elderly and younger patients compared to middle-aged patients, although the difference was not statistically significant. Dysphagia in old age should not be confused with presbyphagia, and a comprehensive evaluation including instrumental analysis should be carried out for a correct diagnosis. Esophageal manometry can be helpful in determining abnormalities in motility in both older and younger patients with dysphagia. The causes of dysphagia vary depending on age, affecting between 1.7% and 11.3% of the general population.